Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials (vol 38, pg 742, 2017)

被引:0
|
作者
不详
机构
基金
英国医学研究理事会;
关键词
D O I
10.1093/eurheartj/ehx277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1403 / 1403
页数:1
相关论文
共 50 条
  • [21] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients with Heart Failure and Preserved Ejection Fraction: The I-PRESERVE Trial
    Lam, Carolyn S.
    Anand, Inder S.
    Carson, Peter E.
    Massie, Barry M.
    Rector, Thomas S.
    Kuskowski, Michael
    McKelvie, Robert S.
    Zile, Michael R.
    McMurray, John J.
    Komajda, Michel
    Kitzman, Dalane W.
    CIRCULATION, 2011, 124 (21)
  • [22] Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
    Kristensen, Soren L.
    Mogensen, Ulrik M.
    Jhund, Pardeep S.
    Petrie, Mark C.
    Preiss, David
    Win, Sithu
    Kober, Lars
    McKelvie, Robert S.
    Zile, Michael R.
    Anand, Inder S.
    Komajda, Michel
    Gottdiener, John S.
    Carson, Peter E.
    McMurray, John J. V.
    CIRCULATION, 2017, 135 (08) : 724 - +
  • [23] Stroke Risk and CHADS2 Score for Risk Stratification in Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
    Badheka, Apurva
    Bhat, Samrat
    Rathod, Ankit
    Kizilbash, Mohammad
    Garg, Neha
    Mohamad, Tamam
    Lai, Zongshan
    Afonso, Luis
    Jacob, Sony
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E64 - E64
  • [24] Importance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction Without Coronary Artery Disease
    Kanazawa, Hisanori
    Tsujita, Kenichi
    CIRCULATION JOURNAL, 2020, 84 (03) : 374 - 375
  • [25] Meta-Analysis of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
    Liu, Gang
    Long, Ming
    Hu, Xun
    Hu, Cheng-Heng
    Du, Zhi-Min
    HEART LUNG AND CIRCULATION, 2021, 30 (05): : 698 - 706
  • [27] Obesity and Its Relationship to Adverse Cardiovascular Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction in the I-PRESERVE Trial
    Kitzman, Dalane W.
    Haas, Marcus M.
    Carson, Peter E.
    Hetzel, Scott
    Komajda, Michael
    Zile, Michael
    Mckelvie, Robert
    Mcmurray, John J.
    Demets, D.
    Staiger, C.
    Ptaszynska, Agata
    Massie, Barry
    CIRCULATION, 2009, 120 (18) : S757 - S758
  • [28] BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL
    Anand, Inderjit S.
    Hetzel, Scott J.
    Miller, Alan B.
    Carson, Peter E.
    Gaasch, William H.
    Haass, Markus
    Little, William C.
    Lopez-Sendon, Jose
    Massie, Barry M.
    McMurray, John J.
    Ptaszynska, Agata
    Teerlink, John R.
    White, Michel
    Zile, Michael R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [29] PROGNOSTIC SIGNIFICANCE OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION PROGRESSION IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE I-PRESERVE TRIAL
    Russo, Cesare
    Jin, Chelsea
    Tao, Lin
    Desai, Kaushal
    Goshorn, Alice
    Donovan, Mark
    Ptaszynska, Agata
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 885 - 885
  • [30] Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
    O'Neal, Wesley T.
    Sandesara, Pratik
    Hammadah, Muhammad
    Venkatesh, Sanjay
    Samman-Tahhan, Ayman
    Kelli, Heval M.
    Soliman, Elsayed Z.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (11): : 1785 - 1790